OPKO Health
OPK
#5848
Rank
HK$9.78 B
Marketcap
HK$13.18
Share price
0.60%
Change (1 day)
33.54%
Change (1 year)

EPS for OPKO Health (OPK)

EPS in 2026 (TTM): -HK$1.49

According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -HK$1.49. In 2025 the company made an earnings per share (EPS) of -HK$2.35 a decrease over its 2024 EPS that were of -HK$0.55.

EPS history for OPKO Health from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.49-36.8%
2025-HK$2.35328.57%
2024-HK$0.55-72%
2023-HK$1.96-43.18%
2022-HK$3.45780%
2021-HK$0.39-200%
2020HK$0.39-109.43%
2019-HK$4.1696.3%
2018-HK$2.12-49.06%
2017-HK$4.161225%
2016-HK$0.31-54.06%
2015-HK$0.68-78.23%
2014-HK$3.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-3,615.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21-1,523.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$368.58-24,826.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-2,478.95%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$96.26-6,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.42-10,526.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$3.53-336.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-HK$1.73 15.79%๐Ÿ‡บ๐Ÿ‡ธ USA